SARS-CoV-2 or Vaccinal Spike Protein Can Induce Mast Cell Activation Syndrome (MCAS)

Overview

Journal Infect Disord Drug Targets

Publisher Bentham Science Publishers

Specialty Infectious Diseases

Date 2024 May 2

PMID 38693735

Authors

Ziad Fajloun

Ziad Abi Khattar

Jean-Marc Sabatier

Affiliations

Soon will be listed here.

Citing Articles

Unveiling the Role of SARS-CoV-2 or mRNA Vaccine Spike Protein in Macrophage Activation Syndrome (MAS).

Fajloun Z, Tajer L, Khattar Z, Sabatier J Infect Disord Drug Targets. 2024; 25(2):e220724232138.

PMID: 39041264 DOI: 10.2174/0118715265341206240722050403.

References

Petra A, Panagiotidou S, Stewart J, Conti P, Theoharides T . Spectrum of mast cell activation disorders. Expert Rev Clin Immunol. 2014; 10(6):729-39. DOI: 10.1586/1744666X.2014.906302. View

Molderings G, Brettner S, Homann J, Afrin L . Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. J Hematol Oncol. 2011; 4:10. PMC: 3069946. DOI: 10.1186/1756-8722-4-10. View

Marshall J, Warrington R, Watson W, Kim H . An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol. 2018; 14(Suppl 2):49. PMC: 6156898. DOI: 10.1186/s13223-018-0278-1. View

Abraham S, St John A . Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol. 2010; 10(6):440-52. PMC: 4469150. DOI: 10.1038/nri2782. View

Metcalfe D, Peavy R, Gilfillan A . Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin Immunol. 2009; 124(4):639-46. PMC: 2788154. DOI: 10.1016/j.jaci.2009.08.035. View

Akin C, Valent P, Metcalfe D . Mast cell activation syndrome: Proposed diagnostic criteria. J Allergy Clin Immunol. 2010; 126(6):1099-104.e4. PMC: 3753019. DOI: 10.1016/j.jaci.2010.08.035. View

Frieri M, Patel R, Celestin J . Mast cell activation syndrome: a review. Curr Allergy Asthma Rep. 2012; 13(1):27-32. DOI: 10.1007/s11882-012-0322-z. View

Annweiler C, Cao Z, Wu Y, Faucon E, Mouhat S, Kovacic H . Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients. Infect Disord Drug Targets. 2020; 20(4):407-408. DOI: 10.2174/1871526520666200518073329. View

El-Arif G, Farhat A, Khazaal S, Annweiler C, Kovacic H, Wu Y . The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19. Molecules. 2021; 26(22). PMC: 8622307. DOI: 10.3390/molecules26226945. View

10.

El-Arif G, Khazaal S, Farhat A, Harb J, Annweiler C, Wu Y . Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases. Molecules. 2022; 27(7). PMC: 9000463. DOI: 10.3390/molecules27072048. View

11.

Khazaal S, Harb J, Rima M, Annweiler C, Wu Y, Cao Z . The Pathophysiology of Long COVID throughout the Renin-Angiotensin System. Molecules. 2022; 27(9). PMC: 9101946. DOI: 10.3390/molecules27092903. View

12.

Fajloun Z, Legros C, Sabatier J . COVID-19 and Ehlers-Danlos Syndrome: The Dangers of the Spike Protein of SARS-CoV-2. Infect Disord Drug Targets. 2023; 23(3):e040123212375. DOI: 10.2174/1871526523666230104145108. View

13.

Fajloun Z, Khattar Z, Kovacic H, Legros C, Sabatier J . Why do Athletes Develop Very Severe or Fatal Forms of COVID after Intense Exercise Following SARS-CoV-2 Infection or Anti-COVID Vaccination?. Infect Disord Drug Targets. 2023; 23(4):e110123212563. DOI: 10.2174/1871526523666230111104355. View

14.

Fajloun Z, Khattar Z, Kovacic H, Legros C, Sabatier J . SIBO: The Trail of a "New" Human Pathology Associated with Multiple Severe and Disabling COVID-19 and Long COVID Symptoms or Induced by the Anti-COVID-19 Vaccine. Infect Disord Drug Targets. 2023; 23(4):e100223213593. DOI: 10.2174/1871526523666230210162334. View

15.

Fajloun Z, Khattar Z, Kovacic H, Legros C, Sabatier J . Anti-COVID-19 Vaccination, COVID-19, and Female Contraception: The Exacerbated Risks (Thromboembolism) of the Estrogen-progestin Pill. Infect Disord Drug Targets. 2023; 23(4):e240223214000. DOI: 10.2174/1871526523666230224094439. View

16.

Fajloun Z, Khattar Z, Kovacic H, Legros C, Sabatier J . Understanding and Relieving of Neuropathic Disorders in the Long COVID. Infect Disord Drug Targets. 2023; 23(4):e270223214061. DOI: 10.2174/1871526523666230227113205. View

17.

Fajloun Z, Khattar Z, Kovacic H, Sabatier J . COVID-19 and Anti-COVID-19 Vaccination: Potential Damages to the Thyroid Gland. Infect Disord Drug Targets. 2023; 23(6):e090523216698. DOI: 10.2174/1871526523666230509112038. View

18.

Fajloun Z, Wu Y, Cao Z, Kovacic H, Sabatier J . COVID-19 and Alzheimer's Disease: The Link Finally Established. Infect Disord Drug Targets. 2023; 23(7):14-16. DOI: 10.2174/1871526523666230529162633. View

19.

Fajloun Z, Wu Y, Cao Z, Kovacic H, Sabatier J . Covid-19 and Parkinson's Disease: the Link also Established!. Infect Disord Drug Targets. 2023; . DOI: 10.2174/1871526523666230619104142. View

20.

Fajloun Z, Khattar Z, Sabatier J . The Intriguing Connection between Cholestasis and the Renin-Angiotensin System Dysregulation Induced by SARS-CoV-2 and/or the Vaccinal Spike Protein. Infect Disord Drug Targets. 2024; 24(7):e080324227802. DOI: 10.2174/0118715265304515240220105152. View